Rocuronium Fresenius 50 mg / 5 ml

Rocuronium Fresenius 50 mg / 5 ml is a medicine authorised by Swissmedic under authorisation number 60566. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 July 2010 and the authorisation is valid without a time limit. ATC code M03AC09 places the medicine in the group Muscle relaxants.

  • Dispensing category B
  • Authorisation number 60566
  • ATC M03AC09
  • Synthetic medicines
Authorisation data
Authorisation number60566
NameRocuronium Fresenius 50 mg / 5 ml
Full nameRocuronium Fresenius 50 mg / 5 ml, Injektionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeM03AC09
First authorisation01 July 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Rocuronium Fresenius 50 mg / 5 ml, InjektionslösungB01 July 2010
3Rocuronium Fresenius 100 mg / 10 ml, InjektionslösungB01 July 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
75Durchstechflasche(n)M03AC0901.13.0.B
810Durchstechflasche(n)M03AC0901.13.0.B
95Durchstechflasche(n)M03AC0901.13.0.B
1010Durchstechflasche(n)M03AC0901.13.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rocuronium Fresenius 50 mg / 5 ml authorised in Switzerland?

Yes. Rocuronium Fresenius 50 mg / 5 ml is authorised by Swissmedic under authorisation number 60566, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Rocuronium Fresenius 50 mg / 5 ml have?

Rocuronium Fresenius 50 mg / 5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rocuronium Fresenius 50 mg / 5 ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com